Close Icon
We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Breast Cancer Trial Landscape Trends, 2008-2017

Female breast cancer is the second most common cancer worldwide in terms of new cases and the leading cause of cancer death in women, according to the Global Cancer Observatory [1]. In women, the number of worldwide cases is predicted to rise from ~2.1 million in 2018 to ~ 3.1 million in 2040, an increase of ~46% [2]. In honor of the San Antonio Breast Cancer Symposium [3], which convenes from December 4-8, 2018, Citeline's oncology team analyzed breast cancer trends from 2008 to 2017 using Trialtrove®.

Informa UK Limited is a company registered in England and Wales with company number 1072954 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Informa UK Limited is part of Informa PLC.